TMPA

N/A

Report date: 2025/01/15 13:54:12

NME

Base Information

Drug NameTMPA

Drug Alias NameTMPA

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase STK11 stimulantsAMP-activated protein kinases activatorsNuclear receptor subfamily 4 group A member 1 degraders

TargetsSerine/threonine-protein kinase STK11AMP-activated protein kinasesNuclear receptor subfamily 4 group A member 1

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesXiamen University

China Registration ClassN/A

Develop Information

Active CompaniesXiamen University

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A